Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 25 Aug 2026 for Rapport Therapeutics, Inc., €1.6M.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Krishnaswamy Yeleswaram: trading record in brief
This profile gathers the share dealings of Krishnaswamy Yeleswaram in Rapport Therapeutics, Inc. In total, 3 filings cover trades dated from 19 August 2026 to 25 August 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 25 August 2026, reports a transaction of €1.6M in Rapport Therapeutics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Krishnaswamy Yeleswaram
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
37,000 shares@ US$49.33CommonSEC144:0001950047-26-008670
11,472 shares@ US$48.240.024% mcap84.3% of flowCommonSEC144:0001950047-26-008594
2,092 shares@ US$49.010.0044% mcap100.0% of flowCommonSEC144:0001950047-26-008426
3 of 3 declarations
